# The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine

> **NCT02592486** · PHASE4 · COMPLETED · sponsor: **Kameda Medical Center** · enrollment: 162 (actual)

## Conditions studied

- Pneumococcal Pneumonia
- Influenza

## Interventions

- **BIOLOGICAL:** Simultaneous administration of Pneumovax NP® and Fluvic HA syringe®
- **BIOLOGICAL:** Sequential administration of Pneumovax NP® and Fluvic HA syringe®

## Key facts

- **NCT ID:** NCT02592486
- **Lead sponsor:** Kameda Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-03
- **Final completion:** 2016-08
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2019-01-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02592486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02592486, "The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02592486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*